By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Molecular diagnostic technology firm Quanterix said today that it will work with Germany's Stratec Biomedical in a partnership to develop, manufacture, and market an automated testing tool aimed at the life sciences and medical in vitro diagnostic markets.

The companies will customize Stratec's technology to develop an automated version of Quanterix's Single Molecule Array (SiMoA) technology.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A fire at a Manchester hospital may have destroyed lab equipment and data, the Guardian reports.

Researchers generate a genetic database from skeletal remains from the 1845 Franklin Expedition to the Arctic, Live Science reports.

Researchers in China have begun another trial using CRISPR/Cas9 approaches in cancer patients, according to the Wall Street Journal.

In Science this week: human DNA found in sediments from archeological sites lacking bones, and more.